An investigation for investors in Boston Scientific Corporation (NYSE:BSX) shares over potential securities laws violations by Boston Scientific was announced and NYSE:BSX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 02/28/2017 -- An investigation on behalf of investors in NYSE:BSX shares was announced concerning possible securities laws violations by Boston Scientific in connection certain financial statements.
Investors who purchased shares of Boston Scientific Corporation (NYSE:BSX), have certain options and should contact the Shareholders Foundation at email@example.com or call 858-779-1554.
The investigation by a law firm focuses on whether a series of statements by Boston Scientific regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On February 23, 2017, Boston Scientific Corporation announced a voluntary removal of all Lotus™ Valve devices, including Lotus with Depth Guard™, from global commercial and clinical sites due to reports of premature release of a pin connecting the Lotus Valve to the delivery system. Boston Scientific Corporation said it believes that the issue is caused by excess tension in the pin mechanism introduced during the manufacturing process. Shares of Boston Scientific Corporation (NYSE:BSX) declined on February 23, 2017 to as low as $23.29 per share.
On February 27, 2017, NYSE:BSX shares closed at $24.81 per share.
Those who purchased shares of Boston Scientific Corporation have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego